ArticleCureus2026
Endoscopic Submucosal Dissection for Esophageal Adenocarcinoma Amidst Variceal Vulnerability.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic submucosal dissection (ESD) has become a curative therapy for early esophageal adenocarcinoma (EAC), yet the presence of esophageal varices poses significant challenges. We present the case of a 67-year-old man with alcoholic cirrhosis and varices who was found to have a short-segment Barrett's esophagus containing a mass at the gastroesophageal junction. Subsequent biopsy confirmed intramucosal adenocarcinoma of the esophagus. Given the patient's poor surgical candidacy, ESD was performed. This case illustrates that carefully planned ESD can be safely executed in select patients with EAC and esophageal varices when standard therapy is contraindicated. It also highlights the possibility of high-risk malignancy even in short-segment Barrett's esophagus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.